Herantis Pharma granted almost 3 million Euro government loan for Parkinson study
Herantis Pharma granted almost 3 million Euro government loan for Parkinson study Herantis Pharma PlcCompany release 30 June 2015 at 10:00 am Tekes, the Finnish Funding Agency for Innovation, has granted a 2,903,000 EUR R&D loan to Herantis Pharma Plc to support its clinical study of CDNF for the treatment of Parkinson's disease. The loan was granted conditionally subject to obtaining regulatory approval for the clinical study. "Tekes funding enables us to conduct this study with an optimal design", appreciates Sigrid Booms, Herantis' Director of Clinical Development. "While that